Comparison of clinical efficacy and cost-quality of antihistamines in early treatment for Japanese cedar pollinosis

Japanese Journal of Allergology

Volumn 55, Issue 5, 2006, Pages 554-565

  Kakutani, Chieko ^a   Ogino, Satoshi ^a   Ikeda, Hiroki ^b   Enomoto, Tadao ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

Author keywords

Antihistamine; Cost quality; Early treatment; Japanese cedar pollinosis

Indexed keywords

ANTIHISTAMINIC AGENT; AZELASTINE; CELESTAMINE; CETIRIZINE; CORTICOSTEROID; EBASTINE; EPINASTINE; FEXOFENADINE; LORATADINE; OXATOMIDE; HISTAMINE H1 RECEPTOR ANTAGONIST;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; DRUG COST; DRUG EFFICACY; FEMALE; HUMAN; JAPANESE CEDAR; MAJOR CLINICAL STUDY; MALE; OCULAR PRURITUS; POLLEN ALLERGY; RHINORRHEA; SNEEZING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; COST; COST BENEFIT ANALYSIS; ECONOMICS; HAY FEVER; JAPAN; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; CRYPTOMERIA; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; JAPAN; MALE; MIDDLE AGED; RHINITIS, ALLERGIC, SEASONAL;

EID: 33748763573     PISSN: 00214884     EISSN: 13477935     Source Type: Journal    
DOI: None     Document Type: Article

References (32)